125 related articles for article (PubMed ID: 3355720)
1. Blood phenylalanine estimation for the patient with phenylketonuria using a portable device.
Peterson K; Slover R; Gass S; Seltzer WK; McCabe LL; McCabe ER
Biochem Med Metab Biol; 1988 Feb; 39(1):98-104. PubMed ID: 3355720
[TBL] [Abstract][Full Text] [Related]
2. Measurement of phenylalanine in blood on filter paper as a method of monitoring PKU treatment.
Tylek-Lemañska D; Otarzewski M; Kostyk E
J Med Screen; 2002; 9(2):64-6. PubMed ID: 12133924
[TBL] [Abstract][Full Text] [Related]
3. Manual fluorometry of phenylalanine from blood specimens collected on filter paper: a modified procedure.
Wu JT; Wu LH; Ziter FA; Ash KO
Clin Chem; 1979 Mar; 25(3):470-2. PubMed ID: 262190
[TBL] [Abstract][Full Text] [Related]
4. Enzymatic control of phenylalanine intake in phenylketonuria.
Hoskins JA; Jack G; Wade HE; Peiris RJ; Wright EC; Starr DJ; Stern J
Lancet; 1980 Feb; 1(8165):392-4. PubMed ID: 6101846
[TBL] [Abstract][Full Text] [Related]
5. Cuban neonatal screening of phenylketonuria using an ultramicro-fluorometric test.
González EC; Frómeta A; del Río L; Castells E; Robaina MS; García SM; Licourt T; Arteaga AL; Martínez L
Clin Chim Acta; 2009 Apr; 402(1-2):129-32. PubMed ID: 19168043
[TBL] [Abstract][Full Text] [Related]
6. A microplate-based enzymatic assay for the simultaneous determination of phenylalanine and tyrosine in serum.
Wibrand F
Clin Chim Acta; 2004 Sep; 347(1-2):89-96. PubMed ID: 15313145
[TBL] [Abstract][Full Text] [Related]
7. An enzymatic assay of plasma phenylalanine and tyrosine for the detection and management of phenylketonuria.
Shen RS; Richardson CJ; Rouse BM; Abell CW
Biochem Med; 1981 Oct; 26(2):211-21. PubMed ID: 7317039
[No Abstract] [Full Text] [Related]
8. Phenylketonuria: a new method for the simultaneous determination of plasma phenylalanine and tyrosine.
Shen RS; Abell CW
Science; 1977 Aug; 197(4304):665-7. PubMed ID: 877580
[TBL] [Abstract][Full Text] [Related]
9. Fluorometric method for phenylalanine microplate assay adapted for phenylketonuria screening.
Gerasimova NS; Steklova IV; Tuuminen T
Clin Chem; 1989 Oct; 35(10):2112-5. PubMed ID: 2791280
[TBL] [Abstract][Full Text] [Related]
10. L-Phenylalanine concentration in blood of phenylketonuria patients: a modified enzyme colorimetric assay compared with amino acid analysis, tandem mass spectrometry, and HPLC methods.
De Silva V; Oldham CD; May SW
Clin Chem Lab Med; 2010 Sep; 48(9):1271-9. PubMed ID: 20604724
[TBL] [Abstract][Full Text] [Related]
11. [Did the change of technique of screening investigations influence on improvement of test credibility in recognizing and differentiating diagnostics of hiperphenylalaninemias?].
Didycz B; Lemańska D; Słuszniak A
Przegl Lek; 2009; 66(1-2):11-3. PubMed ID: 19485249
[TBL] [Abstract][Full Text] [Related]
12. Induction, titration, and maintenance dosing regimen in a phase 2 study of pegvaliase for control of blood phenylalanine in adults with phenylketonuria.
Zori R; Thomas JA; Shur N; Rizzo WB; Decker C; Rosen O; Li M; Schweighardt B; Larimore K; Longo N
Mol Genet Metab; 2018 Nov; 125(3):217-227. PubMed ID: 30146451
[TBL] [Abstract][Full Text] [Related]
13. An extracorporeal hollow-fiber reactor for phenylketonuria using immobilized phenylalanine ammonia lyase.
Larue C; Munnich A; Charpentier C; Saudubray JM; Frézal J; Rémy MH; Rivat C
Dev Pharmacol Ther; 1986; 9(2):73-81. PubMed ID: 3956347
[TBL] [Abstract][Full Text] [Related]
14. Extracorporeal enzyme reactors for depletion of phenylalanine in phenylketonuria.
Ambrus CM; Anthone S; Horvath C; Kalghatgi K; Lele AS; Eapen G; Ambrus JL; Ryan AJ; Li P
Ann Intern Med; 1987 Apr; 106(4):531-7. PubMed ID: 3826953
[TBL] [Abstract][Full Text] [Related]
15. Single-dose, subcutaneous recombinant phenylalanine ammonia lyase conjugated with polyethylene glycol in adult patients with phenylketonuria: an open-label, multicentre, phase 1 dose-escalation trial.
Longo N; Harding CO; Burton BK; Grange DK; Vockley J; Wasserstein M; Rice GM; Dorenbaum A; Neuenburg JK; Musson DG; Gu Z; Sile S
Lancet; 2014 Jul; 384(9937):37-44. PubMed ID: 24743000
[TBL] [Abstract][Full Text] [Related]
16. Partial rescue of neuropathology in the murine model of PKU following administration of recombinant phenylalanine ammonia lyase (pegvaliase).
Goldfinger M; Zeile WL; Corado CR; O'Neill CA; Tsuruda LS; Laipis PJ; Cooper JD
Mol Genet Metab; 2017 Sep; 122(1-2):33-35. PubMed ID: 28506393
[TBL] [Abstract][Full Text] [Related]
17. Phenylalanine ammonia-lyase modified with polyethylene glycol: potential therapeutic agent for phenylketonuria.
Ikeda K; Schiltz E; Fujii T; Takahashi M; Mitsui K; Kodera Y; Matsushima A; Inada Y; Schulz GE; Nishimura H
Amino Acids; 2005 Nov; 29(3):283-7. PubMed ID: 15977040
[TBL] [Abstract][Full Text] [Related]
18. Monitoring of phenylketonuria: a colorimetric method for the determination of plasma phenylalanine using L-phenylalanine dehydrogenase.
Wendel U; Hummel W; Langenbeck U
Anal Biochem; 1989 Jul; 180(1):91-4. PubMed ID: 2817348
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of 6-year application of the enzymatic colorimetric phenylalanine assay in the setting of neonatal screening for phenylketonuria.
Schulze A; Mayatepek E; Hoffmann GF
Clin Chim Acta; 2002 Mar; 317(1-2):27-37. PubMed ID: 11814455
[TBL] [Abstract][Full Text] [Related]
20. Determination of phenylalanine in serum by a modified fluorimetric method in the diagnosis of phenylketonuria.
Cechák P; Zidlický A
Acta Univ Carol Med Monogr; 1977; (79 Pt 3):53-5. PubMed ID: 615483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
